Ilomedin 20

Iloprost trometamol, the active ingredient in Ilomedin 20, is a prostacyclin analog presented as a 20 µg/mL intravenous solution for intravenous use. It treats pulmonary arterial hypertension, digital ulcers associated with systemic sclerosis, and peripheral arterial disease in appropriate patients.

GNH USA supplies Ilomedin 20 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, specialty clinics, transplant centres and pharmacies worldwide, with a focus on quality and regulatory compliance.

Iloprost trometamol is employed in disorders characterized by elevated pulmonary vascular resistance and peripheral vasculopathy.

- Pulmonary arterial hypertension: improves exercise capacity and lowers pulmonary arterial pressure. - Digital ulcers associated with systemic sclerosis: promotes ulcer healing and reduces formation of new lesions. - Peripheral arterial disease: enhances limb perfusion and may alleviate claudication symptoms.

Ilomedin 20 may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity. - Flushing: transient warmth and redness of the skin. - Nausea: occasional gastrointestinal upset. - Diarrhea: loose stools.

Serious or Rare Side Effects: - Hypotension: significant drop in blood pressure requiring medical attention. - Pulmonary edema: accumulation of fluid in the lungs. - Bleeding complications: increased risk of hemorrhage due to platelet inhibition.

When using Ilomedin 20, clinicians should observe specific safety measures.

- Cardiovascular monitoring: observe blood pressure and heart rate during infusion. - Renal impairment: adjust therapy and monitor renal function. - Hepatic dysfunction: use cautiously in patients with liver disease. - Pregnancy: avoid use unless benefits outweigh risks; safety not established. - Concomitant vasodilators: assess for additive hypotensive effect. - Store at ambient temperature: keep below 25 °C, protect from light and moisture, retain in original container.

Ilomedin 20 can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Phosphodiesterase‑5 inhibitors: may cause severe hypotension. - Nitrates: additive vasodilatory effect leading to dangerous blood pressure fall.

Moderate Interactions (Monitor Closely): - Anticoagulants: increased bleeding risk due to platelet inhibition. - Calcium channel blockers: may enhance hypotensive response. - Beta‑blockers: may mask tachycardia signs.